Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 779 

    Article Cited by others

SPECIAL COMMUNICATION

SASLT guidelines: Update in treatment of Hepatitis C virus infection

Alghamdi Abdullah S, Alghamdi Mohammed, Sanai Faisal M, Alghamdi Hamdan, Aba-Alkhail Faisal, Alswat Khalid, Babatin Mohammed, Alqutub Adel, Altraif Ibrahim, Alfaleh Faleh

Year : 2016| Volume: 22| Issue : 8 | Page no: 25-57

   This article has been cited by
 
1 The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia
Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi
Saudi Pharmaceutical Journal. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia
AhmedSaqer Alotaibi, Nour Shamas, UmairUddin Ansari, FaisalM Sanai, Ali Alshahrani, AhmedIbrahim Fathelrahman, MohammedAli Aseeri
Journal of Pharmacy And Bioallied Sciences. 2021; 13(3): 317
[Pubmed]  [Google Scholar] [DOI]
3 A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia
Faisal M. Sanai, Mohammed Alghamdi, Ellen Dugan, Abduljaleel Alalwan, Waleed Al-Hamoudi, Faisal Abaalkhail, Nasser AlMasri, Devin Razavi-Shearer, Homie Razavi, Jonathan Schmelzer, Faleh Z. Alfaleh
Journal of Infection and Public Health. 2020; 13(11): 1715
[Pubmed]  [Google Scholar] [DOI]

 

Read this article